These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37173624)

  • 21. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
    Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
    Front Genet; 2021; 12():779554. PubMed ID: 34880908
    [No Abstract]   [Full Text] [Related]  

  • 22. Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients.
    Li N; Chen J; Yu W; Huang X
    BMC Gastroenterol; 2023 Sep; 23(1):312. PubMed ID: 37710166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.
    Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N
    Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
    Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
    Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
    Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
    BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma.
    Peng B; Li H; Na R; Lu T; Li Y; Zhao J; Zhang H; Zhang L
    Front Cell Dev Biol; 2021; 9():706454. PubMed ID: 34336859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma.
    Sun D; Zhang C
    Oncol Res; 2023; 31(5):753-767. PubMed ID: 37547766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer.
    Guo C; Zhou J; Ma B; Wang R; Ge Y; Wang Z; Ji B; Wang W; Zhang J; Wang Z
    Front Surg; 2021; 8():724792. PubMed ID: 34504866
    [No Abstract]   [Full Text] [Related]  

  • 30. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.
    Lin C; Lin K; Li P; Yuan H; Lin X; Dai Y; Zhang Y; Xie Z; Liu T; Wei C
    Sci Rep; 2024 Jun; 14(1):14460. PubMed ID: 38914679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma.
    Duan BT; Zhao XK; Cui YY; Liu DZ; Wang L; Zhou L; Zhang XY
    World J Gastrointest Surg; 2024 Mar; 16(3):842-859. PubMed ID: 38577085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
    Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
    Front Genet; 2022; 13():874673. PubMed ID: 35547247
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
    Wang C; Wang Z; Zhao Y; Jia R
    BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.
    Chen S; Li X; Zhang J; Li L; Wang X; Zhu Y; Guo L; Wang J
    J Gastrointest Oncol; 2021 Oct; 12(5):2157-2171. PubMed ID: 34790382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma.
    Qi B; Liu H; Zhou Q; Ji L; Shi X; Wei Y; Gu Y; Mizushima A; Xia S
    Aging (Albany NY); 2021 Jul; 13(14):18806-18826. PubMed ID: 34285140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.
    Liu J; Cui G; Ye J; Wang Y; Wang C; Bai J
    Front Cell Dev Biol; 2022; 10():753957. PubMed ID: 35433686
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.
    Jiang Y; Ye Y; Huang Y; Wu Y; Wang G; Gui Z; Zhang M; Zhang M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15069-15083. PubMed ID: 37620430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.